ED SEX PILLS
Call us toll free!
Sitemap

US English / USD - $

Français / EUR - €

Deutch / EUR - €

Español / EUR - €

English / EUR - €

$0.00 (0 items)

Checkout Track Order
 


OUR CUSTOMERS' FEEDBACK

Just to inform you that your package was received Friday 27 th October 14 days after dispatch , excellent service , no problems with customs , also thank you for free extra tablets , you can if you wish use this letter as a recommendation for your company , many thanks

Social bookmarks:


Special Offer!

Other languages:

bookmark Bookmark this site
Subscribe to the News
SitemapSitemap


Our billing is certified by:

Secure shopping certificates

We accept:

News

  • Longtime west Tulsa pharmacist to retire - Tulsa World

    Longtime west Tulsa pharmacist to retireTulsa World29 will mark the last day of business for the old-fashioned community pharmacy, which dates back to 1930.

  • Omnicare Announces Expiration of Its Tender Offer to Acquire PharMerica - MarketWatch (press release)

    Omnicare Announces Expiration of Its Tender Offer to Acquire PharMericaMarketWatch (press release)Covington, KY, USA, Feb 21, 2012 (Thomson Reuters ONE via COMTEX) -- COVINGTON, Ky.

  • Flaws in ESI/Medco efficiency claims exposed - The Pharma Letter

    Flaws in ESI/Medco efficiency claims exposedThe Pharma LetterDavid Balto, an antitrust attorney in Washington DC, USA, and former Policy Director of the Federal Trade Commission, released a white paper yesterday exposing the flaws in efficiency claims made by US pharmacy benefit managers (PBMs) Express Scripts .

  • Red Fork pharmacy closing after 82 years - Tulsa World

    Red Fork pharmacy closing after 82 yearsTulsa WorldThe pharmacy's customer records and leftover drugs are being transferred to Pine Bluff, Ark.

  • Skepticism grows around Medco/Express Scripts deal - Reuters

    WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .